Related Experiment Video
Updated: Jul 27, 2026

07:08
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
7.9K
Systematic optimization of targeted and multiplexed MS-based screening workflows for protein biomarkers
Neelam Khanal1,2, Zhuo Chen1, Yun W Alelyunas2
1Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, Research, GlaxoSmithKline, 1250 South Collegeville Rd., Collegeville, PA 19426, USA.
Bioanalysis
|March 8, 2022
Summary
This study presents a streamlined workflow for simultaneously screening multiple protein biomarkers using mass spectrometry. The optimized method simplifies sample preparation, enabling robust biomarker discovery for diseases like multiple myeloma.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Proteomics
Background:
- Targeted mass spectrometry (MS) enables sensitive, selective multiplexed measurement of biomarkers.
- Complex biological samples necessitate extensive preparation, hindering biomarker discovery.
- Current methods often require specific affinity reagents, limiting broad applicability.
Purpose of the Study:
- To develop and optimize a generic workflow for multiplexed protein biomarker screening.
- To eliminate the need for specific affinity reagents in the screening process.
- To enhance analytical performance through systematic optimization of sample processing and LC-MS methods.
Main Methods:
- Development of a surrogate peptide-based workflow for protein biomarker screening.
- Systematic assessment and optimization of each sample processing step.
- Optimization of liquid chromatography-mass spectrometry (LC-MS) parameters for enhanced performance.
Main Results:
- A generic, affinity reagent-free workflow for multiplexed screening of seven human proteins was established.
- Each stage of sample processing and LC-MS was optimized for improved analytical outcomes.
- The workflow demonstrated robust measurement capabilities for potential biomarkers.
Conclusions:
- The developed method facilitates efficient and sensitive protein biomarker screening.
- The workflow is applicable to complex biological samples, reducing preparation bottlenecks.
- The method was successfully applied to screen multiple myeloma patient samples for potential disease biomarkers.

